187 related articles for article (PubMed ID: 10371180)
1. Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users.
Alexander CS; Dong W; Schechter MT; O'Shaughnessy MV; Strathdee SA; Mo T; Montaner JS; Harrigan PR
AIDS; 1999 May; 13(8):981-5. PubMed ID: 10371180
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.
Salomon H; Wainberg MA; Brenner B; Quan Y; Rouleau D; Coté P; LeBlanc R; Lefebvre E; Spira B; Tsoukas C; Sekaly RP; Conway B; Mayers D; Routy JP
AIDS; 2000 Jan; 14(2):F17-23. PubMed ID: 10708278
[TBL] [Abstract][Full Text] [Related]
3. Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients.
Paolucci S; Baldanti F; Campanini G; Zavattoni M; Cattaneo E; Dossena L; Gerna G
J Med Virol; 2001 Oct; 65(2):207-17. PubMed ID: 11536225
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 drug resistance in newly infected individuals.
Boden D; Hurley A; Zhang L; Cao Y; Guo Y; Jones E; Tsay J; Ip J; Farthing C; Limoli K; Parkin N; Markowitz M
JAMA; 1999 Sep 22-29; 282(12):1135-41. PubMed ID: 10501116
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M
Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586
[TBL] [Abstract][Full Text] [Related]
6. Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Little SJ; Daar ES; D'Aquila RT; Keiser PH; Connick E; Whitcomb JM; Hellmann NS; Petropoulos CJ; Sutton L; Pitt JA; Rosenberg ES; Koup RA; Walker BD; Richman DD
JAMA; 1999 Sep 22-29; 282(12):1142-9. PubMed ID: 10501117
[TBL] [Abstract][Full Text] [Related]
7. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
8. Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid.
Briones C; Pérez-Olmeda M; Rodríguez C; del Romero J; Hertogs K; Soriano V
J Acquir Immune Defic Syndr; 2001 Feb; 26(2):145-50. PubMed ID: 11242181
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.
Sadeghi L; Lolaie M; Tabatabai RA; Bayanolhagh S; Taj L; Ahmadi NE; Abedinzadeh N; Vakili F; Ahmadi G; Mohraz M
Infect Disord Drug Targets; 2018; 18(3):241-248. PubMed ID: 29663899
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals.
Shafer RW; Warford A; Winters MA; Gonzales MJ
J Virol Methods; 2000 May; 86(2):143-53. PubMed ID: 10785289
[TBL] [Abstract][Full Text] [Related]
12. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858
[TBL] [Abstract][Full Text] [Related]
13. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
[TBL] [Abstract][Full Text] [Related]
14. Profile of HIV type 1 infection and genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV type 1-infected individuals in Hai Phong, Viet Nam.
Ishizaki A; Cuong NH; Thuc PV; Trung NV; Saijoh K; Kageyama S; Ishigaki K; Tanuma J; Oka S; Ichimura H
AIDS Res Hum Retroviruses; 2009 Feb; 25(2):175-82. PubMed ID: 19239356
[TBL] [Abstract][Full Text] [Related]
15. Rapid detection of drug resistant HIV -1 to reverse transcriptase and protease inhibitors in HIV-infected patients receiving highly active antiretroviral therapies.
Yu M; Kabat W; Wang J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):325-9. PubMed ID: 11471017
[TBL] [Abstract][Full Text] [Related]
16. Genotypic analysis of the protease and reverse transcriptase of HIV type 1 isolates from recently infected injecting drug users in western China.
Liao L; Xing H; Li X; Ruan Y; Zhang Y; Qin G; Shao Y
AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1062-5. PubMed ID: 17725425
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.
Venturi G; Catucci M; Romano L; Corsi P; Leoncini F; Valensin PE; Zazzi M
J Infect Dis; 2000 Feb; 181(2):740-5. PubMed ID: 10669367
[TBL] [Abstract][Full Text] [Related]
18. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
[TBL] [Abstract][Full Text] [Related]
19. Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients.
Birk M; Sönnerborg A
AIDS; 1998 Dec; 12(18):2369-75. PubMed ID: 9875574
[TBL] [Abstract][Full Text] [Related]
20. Compartmentalization of drug resistance-associated mutations in a treatment-naive HIV-infected female.
Tirado G; Jove G; Kumar R; Noel RJ; Reyes E; Sepulveda G; Yamamura Y; Kumar A
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):684-6. PubMed ID: 15242547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
